Hepatitis C Screening May Boost Opioid Treatment Success 

Being Overweight Increases Cancer Risk, Two New Studies Show
November 3, 2017
9 countries are on track to completely eradicate hepatitis C
November 6, 2017
Show all

Hepatitis C Screening May Boost Opioid Treatment Success 

Opioid abuse therapy may be more effective if patients are screened for hepatitis C as part of the program, a new Canadian study says.

The research found a sharp drop in opioid abuse among patients after they were told they tested positive for the hepatitis C virus (HCV). Hepatitis C causes liver disease that can lead to cirrhosis (scarring of the liver), liver cancer and liver failure, the researchers said.

“Our study showed awareness of HCV infection among this particular population may motivate them to reduce their consumption and hopefully high-risk behavior,” said lead investigator Dr. Hooman Farhang Zangneh, a postdoctoral research fellow at the Toronto Centre for Liver Disease at Toronto General Hospital.

Read full article: Hepatitis C Screening May Boost Opioid Treatment Success | Health Care | US News

Read Full Article: Hepatitis C Screening May Boost Opioid Treatment Success | Health Care | US News 

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.